Anti-ARF1 [ARFS 5F2/2]
Invented by Dr Sharon Tooze from The Francis Crick Institute
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151248 |
| Applications | ELISA |
| Antigen/Gene or Protein Targets | ADP-Ribosylation Factor 1 (ARF1) |
| Reactivity | Human |
| Relevance | ARF1 is a member of the ARF family of small G proteins and is a component of Golgi-derived non-clathrin coated vesicles. |
| Host | Mouse |
| Immunogen | C-terminal Human ARF1 peptide SNQLRNQ |
| Subclass | IgM |
| Myeloma Used | Sp2/0-Ag14 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Strain | Balb/c |
| Notes | ARFS 5F2/2 is Class 1 ARF specific. |
| Research Area | Cell Signaling & Signal Transduction |
References: 2 entries
Austin et al. 2000. J Biol Chem. 275(29):21862-9. PMID: 10807927.
Direct and GTP-dependent interaction of ADP-ribosylation factor 1 with clathrin adaptor protein AP-1 on immature secretory granules.
Europe PMC ID: 10807927
Add a reference
References: 2 entries
Austin et al. 2000. J Biol Chem. 275(29):21862-9. PMID: 10807927.
Direct and GTP-dependent interaction of ADP-ribosylation factor 1 with clathrin adaptor protein AP-1 on immature secretory granules.
Add a reference
